Does NIVOLUMAB Cause Hepatic enzyme increased? 450 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 450 reports of Hepatic enzyme increased have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.5% of all adverse event reports for NIVOLUMAB.
450
Reports of Hepatic enzyme increased with NIVOLUMAB
0.5%
of all NIVOLUMAB reports
52
Deaths
190
Hospitalizations
How Dangerous Is Hepatic enzyme increased From NIVOLUMAB?
Of the 450 reports, 52 (11.6%) resulted in death, 190 (42.2%) required hospitalization, and 29 (6.4%) were considered life-threatening.
Is Hepatic enzyme increased Listed in the Official Label?
Yes, Hepatic enzyme increased is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Hepatic enzyme increased?
METHOTREXATE (9,857)
ADALIMUMAB (8,693)
TOCILIZUMAB (7,691)
ETANERCEPT (7,481)
ABATACEPT (7,397)
RITUXIMAB (7,247)
LEFLUNOMIDE (7,173)
INFLIXIMAB (6,778)
HYDROXYCHLOROQUINE (6,555)
TOFACITINIB (6,269)
Which NIVOLUMAB Alternatives Have Lower Hepatic enzyme increased Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE